Cargando…

Karonudib is a promising anticancer therapy in hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is the most common form of liver cancer and is generally caused by viral infections or consumption of mutagens, such as alcohol. While liver transplantation and hepatectomy is curative for some patients, many relapse into disease with few treatment options...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hua, Xiangwei, Sanjiv, Kumar, Gad, Helge, Pham, Therese, Gokturk, Camilla, Rasti, Azita, Zhao, Zhenjun, He, Kang, Feng, Mingxuan, Zang, Yunjin, Zhang, Jianjun, Xia, Qiang, Helleday, Thomas, Warpman Berglund, Ulrika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710815/ https://www.ncbi.nlm.nih.gov/pubmed/31489034 http://dx.doi.org/10.1177/1758835919866960

Ejemplares similares

Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphoma
por: Oksvold, Morten P., et al.
Publicado: (2021)

NEIL3 Prevents Senescence in Hepatocellular Carcinoma by Repairing Oxidative Lesions at Telomeres during Mitosis
por: Zhao, Zhenjun, et al.
Publicado: (2021)

MutT Homolog 1 Inhibitor Karonudib Attenuates Autoimmune Hepatitis by Inhibiting DNA Repair in Activated T Cells
por: Chen, Yong, et al.
Publicado: (2021)

A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma
por: Einarsdottir, Berglind O., et al.
Publicado: (2018)

Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma
por: Einarsdottir, Berglind O., et al.
Publicado: (2020)

Stereospecific targeting of MTH1 by (S)-crizotinib as anticancer strategy
por: Huber, Kilian V. M., et al.
Publicado: (2014)

Glioblastoma and glioblastoma stem cells are dependent on functional MTH1
por: Pudelko, Linda, et al.
Publicado: (2017)

Correction: Glioblastoma and glioblastoma stem cells are dependent on functional MTH1
por: Pudelko, Linda, et al.
Publicado: (2020)

MutT homologue 1 (MTH1) catalyzes the hydrolysis of mutagenic O6-methyl-dGTP
por: Jemth, Ann-Sofie, et al.
Publicado: (2018)

Mutations in Cancer Cause Gain of Cysteine, Histidine, and Tryptophan at the Expense of a Net Loss of Arginine on the Proteome Level
por: Tsuber, Viktoriia, et al.
Publicado: (2017)

MTH1 Inhibitor TH1579 Induces Oxidative DNA Damage and Mitotic Arrest in Acute Myeloid Leukemia
por: Sanjiv, Kumar, et al.
Publicado: (2021)

Overexpressed c-Myc Sensitizes Cells to TH1579, a Mitotic Arrest and Oxidative DNA Damage Inducer
por: Henriksson, Sofia, et al.
Publicado: (2022)

AXL and CAV-1 play a role for MTH1 inhibitor TH1579 sensitivity in cutaneous malignant melanoma
por: Das, Ishani, et al.
Publicado: (2020)

Crystal structure, biochemical and cellular activities demonstrate separate functions of MTH1 and MTH2
por: Carter, Megan, et al.
Publicado: (2015)

MutT homologue 1 (MTH1) removes N6-methyl-dATP from the dNTP pool
por: Scaletti, Emma Rose, et al.
Publicado: (2020)

Broadly Active Antiviral Compounds Disturb Zika Virus Progeny Release Rescuing Virus-Induced Toxicity in Brain Organoids
por: Pettke, Aleksandra, et al.
Publicado: (2020)

In silico Druggability Assessment of the NUDIX Hydrolase Protein Family as a Workflow for Target Prioritization
por: Michel, Maurice, et al.
Publicado: (2020)

TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model
por: Moukengue, Brice, et al.
Publicado: (2020)

Targeting OGG1 arrests cancer cell proliferation by inducing replication stress
por: Visnes, Torkild, et al.
Publicado: (2020)

Small molecule inhibitor of OGG1 blocks oxidative DNA damage repair at telomeres and potentiates methotrexate anticancer effects
por: Baquero, Juan Miguel, et al.
Publicado: (2021)

Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities
por: Sanjiv, Kumar, et al.
Publicado: (2015)

Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities
por: Sanjiv, Kumar, et al.
Publicado: (2016)

Global survey of the immunomodulatory potential of common drugs
por: Vladimer, Gregory I., et al.
Publicado: (2017)

Design, synthesis and biological potential of heterocyclic benzoxazole scaffolds as promising antimicrobial and anticancer agents
por: Kakkar, Saloni, et al.
Publicado: (2018)

Computational and Experimental Druggability Assessment of Human DNA Glycosylases
por: Michel, Maurice, et al.
Publicado: (2019)

Lithium: A Promising Anticancer Agent
por: Villegas-Vázquez, Edgar Yebrán, et al.
Publicado: (2023)

Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy
por: Rudd, Sean G, et al.
Publicado: (2020)

Vitamin D as a promising anticancer agent
por: Chakraborti, Chandra Kanti
Publicado: (2011)

The Promise of Integrins as Effective Targets for Anticancer Agents
por: Rust, William L., et al.
Publicado: (2002)

Signal Transduction Inhibitors as Promising Anticancer Agents
por: Kumar, Raj, et al.
Publicado: (2015)

A phenomics approach for antiviral drug discovery
por: Rietdijk, Jonne, et al.
Publicado: (2021)

Crystal structures of NUDT15 variants enabled by a potent inhibitor reveal the structural basis for thiopurine sensitivity
por: Rehling, Daniel, et al.
Publicado: (2021)

ZnO Nanoparticles: A Promising Anticancer Agent
por: Bisht, Gunjan, et al.
Publicado: (2016)

The Phylum Bryozoa as a Promising Source of Anticancer Drugs
por: Figuerola, Blanca, et al.
Publicado: (2019)

Mitochondrial Redox Hubs as Promising Targets for Anticancer Therapy
por: Ippolito, Luigi, et al.
Publicado: (2020)

Phenothiazines Modified with the Pyridine Ring as Promising Anticancer Agents
por: Morak-Młodawska, Beata, et al.
Publicado: (2021)

Macrophages as Promising Carriers for Nanoparticle Delivery in Anticancer Therapy
por: Wróblewska, Anna, et al.
Publicado: (2023)

Intralesional therapy for advanced melanoma: promise and limitation
por: Agarwala, Sanjiv S.
Publicado: (2015)

Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses
por: Tampere, Marianna, et al.
Publicado: (2020)

Geroprotection: A promising future
por: Magon, Navneet, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_or4p7qtq4pf6vebp9dj4kn0p7j